Opko Health Stock Buy Hold or Sell Recommendation
| OPK Stock | USD 1.48 0.03 2.07% |
Considering the 90-day investment horizon and your highly speculative risk level, our recommendation regarding Opko Health is 'Strong Sell'. The recommendation algorithm takes into account all of Opko Health's available fundamental, technical, and predictive indicators you will find on this site.
Check out Opko Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide. Note, we conduct extensive research on individual companies such as Opko and provide practical buy, sell, or hold advice based on investors' constraints. Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Opko |
Execute Opko Health Buy or Sell Advice
The Opko recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Opko Health. Macroaxis does not own or have any residual interests in Opko Health or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Opko Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Opko Health Trading Alerts and Improvement Suggestions
| Opko Health may become a speculative penny stock | |
| The company reported the last year's revenue of 863.5 M. Reported Net Loss for the year was (188.86 M) with profit before taxes, overhead, and interest of 214.3 M. | |
| Opko Health has about 210.46 M in cash with (28.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. | |
| Roughly 54.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from investors.com: How IBD Stock Of The Day GeneDx Landed On The IBD 50 And Notched A 2,500 percent Gain |
Opko Health Returns Distribution Density
The distribution of Opko Health's historical returns is an attempt to chart the uncertainty of Opko Health's future price movements. The chart of the probability distribution of Opko Health daily returns describes the distribution of returns around its average expected value. We use Opko Health price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Opko Health returns is essential to provide solid investment advice for Opko Health.
| Mean Return | 0.01 | Value At Risk | -3.11 | Potential Upside | 3.29 | Standard Deviation | 2.18 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Opko Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Opko Stock Institutional Investors
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 2.3 M | Ing Investment Management Llc | 2024-09-30 | 2.1 M | Jpmorgan Chase & Co | 2024-09-30 | 1.8 M | Y.d. More Investments Ltd | 2024-09-30 | 1.7 M | Assenagon Asset Management Sa | 2024-09-30 | 1.5 M | Norges Bank | 2024-06-30 | 1.3 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.3 M | Awm Investment Company Inc | 2024-09-30 | 1.3 M | Tejara Capital Ltd | 2024-09-30 | 1.1 M | Rubric Capital Management Lp | 2024-09-30 | 48.7 M | Blackrock Inc | 2024-06-30 | 29.2 M |
Opko Health Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (13.2M) | 62.5M | 18.5M | (57.3M) | (51.6M) | (49.0M) | |
| Free Cash Flow | 5.8M | 6.2M | (119.8M) | (44.5M) | (40.0M) | (42.0M) | |
| Depreciation | 85.4M | 78.7M | 108.7M | 105.3M | 121.1M | 127.1M | |
| Other Non Cash Items | (3.5M) | (13.5M) | 137.8M | 22.0M | 25.3M | 26.9M | |
| Capital Expenditures | 33.7M | 32.2M | 24.6M | 16.3M | 18.7M | 9.4M | |
| Net Income | 30.6M | (30.1M) | (328.4M) | (188.9M) | (170.0M) | (161.5M) | |
| End Period Cash Flow | 72.2M | 134.7M | 153.2M | 95.9M | 110.3M | 63.7M | |
| Change To Netincome | 11.0M | 104.8M | 19.9M | 9.3M | 10.7M | 10.2M | |
| Change To Inventory | (77.6M) | 30.7M | 13.7M | 15.2M | 17.5M | 18.4M | |
| Investments | 15.1M | 6.1M | 91.0M | (24.7M) | (28.3M) | (26.9M) | |
| Change Receivables | 20.4M | 7.4M | (150.4M) | 5.2M | 4.7M | 4.9M | |
| Net Borrowings | 47.2M | 99.2M | (35.8M) | (11.4M) | (10.3M) | (9.8M) |
Opko Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Opko Health or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Opko Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Opko stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0 | |
β | Beta against Dow Jones | -0.08 | |
σ | Overall volatility | 2.20 | |
Ir | Information ratio | -0.0043 |
Opko Health Volatility Alert
Opko Health currently demonstrates below-average downside deviation. It has Information Ratio of 0.0 and Jensen Alpha of 0.0. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Opko Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Opko Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Opko Health Fundamentals Vs Peers
Comparing Opko Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Opko Health's direct or indirect competition across all of the common fundamentals between Opko Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as Opko Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Opko Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Opko Health to competition |
| Fundamentals | Opko Health | Peer Average |
| Return On Equity | -0.0939 | -0.31 |
| Return On Asset | -0.0897 | -0.14 |
| Profit Margin | (0.19) % | (1.27) % |
| Operating Margin | (0.62) % | (5.51) % |
| Current Valuation | 1.1 B | 16.62 B |
| Shares Outstanding | 672.8 M | 571.82 M |
| Shares Owned By Insiders | 54.48 % | 10.09 % |
| Shares Owned By Institutions | 27.96 % | 39.21 % |
| Number Of Shares Shorted | 84.8 M | 4.71 M |
| Price To Earning | 7.46 X | 28.72 X |
| Price To Book | 0.71 X | 9.51 X |
| Price To Sales | 1.40 X | 11.42 X |
| Revenue | 863.5 M | 9.43 B |
| Gross Profit | 214.3 M | 27.38 B |
| EBITDA | (65.52 M) | 3.9 B |
| Net Income | (188.86 M) | 570.98 M |
| Cash And Equivalents | 210.46 M | 2.7 B |
| Cash Per Share | 0.27 X | 5.01 X |
| Total Debt | 326.56 M | 5.32 B |
| Debt To Equity | 0.16 % | 48.70 % |
| Current Ratio | 2.30 X | 2.16 X |
| Book Value Per Share | 2.06 X | 1.93 K |
| Cash Flow From Operations | (28.2 M) | 971.22 M |
| Short Ratio | 16.72 X | 4.00 X |
| Earnings Per Share | (0.19) X | 3.12 X |
| Price To Earnings To Growth | (2.87) X | 4.89 X |
| Target Price | 3.96 | |
| Number Of Employees | 3.93 K | 18.84 K |
| Beta | 1.65 | -0.15 |
| Market Capitalization | 995.74 M | 19.03 B |
| Total Asset | 2.01 B | 29.47 B |
| Retained Earnings | (2.01 B) | 9.33 B |
| Working Capital | 109.42 M | 1.48 B |
Note: Acquisition by Phillip Frost of 125000 shares of Opko Health at 1.595 subject to Rule 16b-3 [view details]
Opko Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Opko . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Opko Health Buy or Sell Advice
When is the right time to buy or sell Opko Health? Buying financial instruments such as Opko Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Opko Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Healthcare theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Opko Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.